ROWLAND CHARLES A JR enters ORCHARD THERAPEUTICS PLC with 12.29K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 1/2/2020ACC: 0001209191-20-000290
Director
Since Jan 2020
12.29K
Baseline shares
100% direct
12.29K
Direct ownership
1 position
115.03K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Ordinary Shares
DirectShares owned12.29K
Total
12.29K direct12.29K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 12.29K | Direct |
| Total | 12.29K | 12.29K direct |
Derivative Holdings2
Stock Option (Right to Buy)
DirectUnderlying security
Ordinary Shares
Underlying shares
35K
Shares owned
N/A
Exercise price
13.20
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Ordinary Shares
Underlying shares
80.03K
Shares owned
N/A
Exercise price
4.74
Expiration
—
Exercise window
—
Total
Underlying
115.03K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Ordinary Shares | 13.20 | — | — | 35K | N/A |
| Stock Option (Right to Buy) Direct | Ordinary Shares | 4.74 | — | — | 80.03K | N/A |
| Total | 115.03K | 0.00 | ||||